Analysis of Main Demand Products and Enterprises of Pachyrhizua Angulatus

Pachyrhizua angulatusthe amount of consumption is much larger than the amount of medicinal use
Powdered kudzu is a dual-use species for medicine and food, and is mainly for consumption, generally 70% for consumption and 30% for medicinal use.
In Guangdong Province, for example, powdered kudzu has become a common household ingredient, which can be used for frying, chilling, soup and congee; it is indispensable for local people. At the same time, kudzu is also exported from Guangdong and Guangxi to Hong Kong, China, as well as Singapore and Malaysia every year.
The supply of real medicinal kudzu in the market is limited, and, except for the content at the reed head, the active ingredient content of annual kudzu is hardly up to standard. Therefore, the powdered kudzu is mainly circulated in the market in three sizes: dice, slices and strips, and the demand for finished medicine is mainly for Chai Kudzu root, with limited amount of powdered kudzu.
According to the statistics of Tiandi Yuntu Chinese medicine industry big data platform, powdered kudzu root is mainly consumed in edible channels, and the demand for powdered kudzu in 2020 is 38,800 tons, and the demand for powdered kudzu in 2021 is about 37,860 tons.
Among them, the consumption of medicinal channel is less than 15%, only about 5600 tons (mainly the drinking channel), and the others are basically made as ingredients or soup material.
Analysis of main demand products and enterprises
In terms of demand for pCms, the 7,702 varieties of pCms monitored by the platform are screened, and there are 6 pCms containing powder kudzu, and the top pCms in demand are Jin Lida granules, Li Brain Heart capsule, Ginseng Astragalus Wu Wei Zi capsule, etc. The overall consumption is not large.
Ltd., Jilin Aodong Yanbian Pharmaceutical Co., Ltd. and Shaanxi Dongtai Pharmaceutical Co.
The future market forecast
1 Pink kudzu market is at a low price, but farmers have a good income Although the current price of pink kudzu rose by more than 40% compared to the lowest point in February 2021, its price is still at a low level compared to other species. Even as a vegetable, the price of kudzu at $1.60/catty is not high. But because of the fresh yield of 4,000 pounds per mu up and down, the gross revenue per mu is 6,500 yuan up and down, excluding costs, farmers can gain more than 3,000 yuan per mu. Although the low price but the profit is still available, but also the main reason why the price of the species is not high year-round.
2 Edible demand increased medicinal demand stagnation In recent years, with the increased awareness of people's health care, powdered kudzu in food therapy, medicinal supplements and other aspects of consumption is increasing. The demand for edible use has increased greatly and the amount of medicinal use is low, so once the medicinal use increases, the edible stock part can quickly replenish the gap.
To sum up, the origin and processing of powdered kudzu is relatively concentrated, the source of goods movement is easy to control, and more concerned merchants. But because the current price of 12 yuan is not as high as the historical price of 28 yuan in 2014, but farmers have a good income, there is still planting enthusiasm, the market price even if there is an increase, there will not be much space.
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Discover Your Next Japanese Product at "JAPAN'S FOOD" EXPORT FAIR Winter 2026
-
Profits from China's chemical raw materials and products manufacturing industry increased by 0.3% in the first two months of 2024
-
With the Operating Load Declining, Will the Monoammonium Phosphate Market Be Supported?
-
Pierre Fabre established a new cosmetics innovation center in Shanghai, China
-
The EU evaluates the safety of a D-tagnose 3-epimerase
-
The EU identified six active substances that do not require MRL review
-
The EU evaluates the safety of α-amylase produced by the transgenic Bacillus subtilis strain AR-651
-
The EU evaluates the safety of phospholipase A10 produced by the transgenic Streptomyces viasura strain AS-2
-
The EU modifies Clostridium butyrate FERM BP-2789 as a condition for the authorization of feed additives for fattening chickens, laying hens and small poultry
-
The EU evaluates the safety of a D-tagnose 3-epimerase
Recommend Reading
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
EU Set to Seek Import Quotas on PET, Epoxy Resins and Fibreglass as Trade Curbs Reach Chemicals
-
This week, the market price of propylene oxide in China has risen (12.1-12.3)
-
Premium Global Chemical Sourcing Requests (14 - 18 Mar, 2026)
-
Imidazole: Heterocyclic Chemistry, Antifungal Drugs, and Buffer Systems
-
Butadiene Rubber Market Prices Surge Sharply
-
Hydrogen Peroxide Formula: H2O2 Concentration & Safety